Cardiac Dimensions

Cardiac Dimensions is a medical device company that develops the Carillon Mitral Contour System, a treatment designed for functional mitral regurgitation (FMR). The Carillon Therapy offers a less invasive option for patients suffering from heart failure with FMR, working in harmony with the heart’s natural structure and function. The Carillon Mitral Contour System has received CE Mark (0344) approval and is available for sale in Europe and other countries recognizing the CE Mark. In the United States, the Carillon System is classified as an investigational device and is currently limited to investigational use. Cardiac Dimensions is actively enrolling patients in the U.S. pivotal EMPOWER Trial, targeting heart failure patients with large ventricles and functional mitral regurgitation. The company is headquartered in Kirkland, Washington, and operates in the United States, Australia, and Germany.